GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson Chemical Pharmaceutical Works Co (ROCO:4747) » Definitions » Net Income (Continuing Operations)

Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Net Income (Continuing Operations) : NT$85.4 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Johnson Chemical Pharmaceutical Works Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Johnson Chemical Pharmaceutical Works Co's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was NT$21.6 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$85.4 Mil.


Johnson Chemical Pharmaceutical Works Co Net Income (Continuing Operations) Historical Data

The historical data trend for Johnson Chemical Pharmaceutical Works Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson Chemical Pharmaceutical Works Co Net Income (Continuing Operations) Chart

Johnson Chemical Pharmaceutical Works Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.56 49.10 64.85 79.70 84.12

Johnson Chemical Pharmaceutical Works Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.36 22.66 21.19 19.92 21.59

Johnson Chemical Pharmaceutical Works Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$85.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Johnson Chemical Pharmaceutical Works Co  (ROCO:4747) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Johnson Chemical Pharmaceutical Works Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Johnson Chemical Pharmaceutical Works Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson Chemical Pharmaceutical Works Co Business Description

Traded in Other Exchanges
N/A
Address
Sanhe Road, No. 77 and No. 79, Section 4, Sanchong District, New Taipei, TWN, 241
Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. Its organization revenue mainly comes from medical product sales.

Johnson Chemical Pharmaceutical Works Co Headlines

No Headlines